Difference between revisions of "Part:BBa K2549035"
Line 2: Line 2:
 
<partinfo>BBa_K2549035 short</partinfo>
 
<partinfo>BBa_K2549035 short</partinfo>
  
−
This part is one of the response elements of our amplifier, also executing the combiner function. 8*ZF21.16 binding sites ([[Part:BBa_K2446015]]) and 8*ZF43.8 binding sites ([[Part:BBa_K2446013]]) can bind to different zinc finger-based transcription activator ZF21.16-VP64 ([[Part:BBa_K2549023]]) and zinc finger-based repressor ZF43.8-KRAB ([[Part:BBa_K2446041]]), respectively, with high orthogonality. Minimal CMV ([[Part:BBa_K2549049]]) is a promotor providing very low basal expression and high maximal expression after induction. This part was designed to construct our NIMPLY logic gate and test our multiple binding sites amplifier model<ref>http://2018.igem.org/Team:Fudan/Model#Transcriptional_Amplifer</ref>.
+
This part is one of the response elements of our amplifier, also executing the combiner function. 8*ZF21.16 binding sites ([[Part:BBa_K2446015]]) and 8*ZF43.8 binding sites ([[Part:BBa_K2446013]]) can bind to different zinc finger-based transcription activator ZF21.16-VP64 ([[Part:BBa_K2549023]]) and zinc finger-based repressor ZF43.8-KRAB ([[Part:BBa_K2446041]]), respectively, with high orthogonality. Minimal CMV2 ([[Part:BBa_K2549060]]) is a promotor providing very low basal expression and high maximal expression after induction. It is also more sensitive to the transcription regulation and less effected by the steric effect caused by the increase of response elements around than minimal CMV. This part was designed to construct our NIMPLY logic gate and test our multiple binding sites amplifier model<ref>http://2018.igem.org/Team:Fudan/Model#Transcriptional_Amplifer</ref>.
  
 
<!-- -->
 
<!-- -->

Revision as of 08:49, 13 October 2018

8*ZF21.16-minCMV-8*ZF43.8

This part is one of the response elements of our amplifier, also executing the combiner function. 8*ZF21.16 binding sites (Part:BBa_K2446015) and 8*ZF43.8 binding sites (Part:BBa_K2446013) can bind to different zinc finger-based transcription activator ZF21.16-VP64 (Part:BBa_K2549023) and zinc finger-based repressor ZF43.8-KRAB (Part:BBa_K2446041), respectively, with high orthogonality. Minimal CMV2 (Part:BBa_K2549060) is a promotor providing very low basal expression and high maximal expression after induction. It is also more sensitive to the transcription regulation and less effected by the steric effect caused by the increase of response elements around than minimal CMV. This part was designed to construct our NIMPLY logic gate and test our multiple binding sites amplifier model[1].

Sequence and Features


Assembly Compatibility:
  • 10
    COMPATIBLE WITH RFC[10]
  • 12
    COMPATIBLE WITH RFC[12]
  • 21
    COMPATIBLE WITH RFC[21]
  • 23
    COMPATIBLE WITH RFC[23]
  • 25
    COMPATIBLE WITH RFC[25]
  • 1000
    COMPATIBLE WITH RFC[1000]


Biology

It works as we designed

@@@@

Different transcription factors interaction with multiple binding sites

Promotor operator numbers can have an impact on tuning output

Synthetic promotor operators regulated by artificial zinc finger-based transcription factors

Khalil AS et al have reported several synthetic promotor operators which can interact with artificial zinc finger-based transcription factors with high specificity and high orthogonality[2].

Khalil AS et al stated:sTFs constructed from OPEN-engineered ZFs are orthogonal to one another. sTF43-8 activated noncognate Promoter21-16 due to the fortuitous creation of a sequence that is significantly similar to the binding sequence of 43-8, when the downstream BamHI restriction site is considered.
Khalil AS et al stated:Tuning up output strength by increasing ZF operator number in synthetic promoter (sTF43-8).


References

  1. ↑ http://2018.igem.org/Team:Fudan/Model#Transcriptional_Amplifer
  2. ↑ A synthetic biology framework for programming eukaryotic transcription functions. Khalil AS, Lu TK, Bashor CJ, ..., Joung JK, Collins JJ. Cell, 2012 Aug;150(3):647-58 PMID: 22863014; DOI: 10.1016/j.cell.2012.05.045